NCT03666351View on ClinicalTrials.gov

Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

October 18, 2018

Primary Completion Date

July 25, 2022

Study Completion Date

July 25, 2022

Conditions
Aortic StenosisAortic RegurgitationHypertensionLVMLeft Ventricular Hypertrophy
Interventions
DRUG

Amlodipine 5mg

Amlodipine 5 mg

DRUG

Losartan

Losartan Potassium 50 mg

DRUG

Losartan and Amlodipine

Amlodipine 5 mg/Losartan Potassium 50 mg, Amlodipine 5 mg/Losartan Potassium 100 mg

DRUG

Amlodipine/Losartan/Chlorthalidone

Amlodipine 5 mg/Losartan Potassium 100 mg/Chlorthalidone 12.5 mg

DRUG

current treatment

treatment is done by maintaining the current treatment

Trial Locations (1)

Unknown

10 Institutions Including Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT03666351 - Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease | Biotech Hunter | Biotech Hunter